Modelling hepatitis C transmission over a social network of injecting drug users
David A. Rolls(Australian Psychological Society), Garry Robins(University of Melbourne), Rachel Sacks‐Davis(Burnet Institute), Galina Daraganova(University of Melbourne), Philippa Pattison(University of Melbourne), Margaret Hellard(Burnet Institute), Rebecca Jenkinson(Burnet Institute), Emma S. McBryde(The Royal Melbourne Hospital)
Cited by 54
Related Papers
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
|Hepatology|2013|393
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
|Clinical Infectious Diseases|2009|234
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2018|228